Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
Authors
Shortt, Conor PGleeson, Tadhg G
Breen, Karen A
McHugh, John
O'Connell, Martin J
O'Gorman, Peter J
Eustace, Stephen J
Affiliation
Department of Radiology and Diagnostic Imaging, Mater Misericordiae University Hospital, Dublin, Ireland.Issue Date
2009-04MeSH
AdultAged
Aged, 80 and over
Biopsy
Female
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Myeloma
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Sensitivity and Specificity
Whole Body Imaging
Metadata
Show full item recordCitation
Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. 2009, 192 (4):980-6 AJR Am J RoentgenolPublisher
AJR. American journal of roentgenologyJournal
AJR. American journal of roentgenologyDOI
10.2214/AJR.08.1633PubMed ID
19304704Abstract
The purpose of this study was to compare FDG PET; whole-body MRI; and the reference standard, bone marrow aspiration and biopsy, to determine the best imaging technique for assessment of disease activity in multiple myeloma.Item Type
ArticleLanguage
enISSN
1546-3141ae974a485f413a2113503eed53cd6c53
10.2214/AJR.08.1633
Scopus Count
Collections
Related articles
- Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
- Authors: Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS
- Issue date: 2008 May
- 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
- Authors: Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
- Issue date: 2008 Feb
- A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
- Authors: Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M
- Issue date: 2007 Jan
- Value of FDG PET in the assessment of patients with multiple myeloma.
- Authors: Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R
- Issue date: 2005 Apr
- "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
- Authors: Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G
- Issue date: 2011 Jun